Hints and tips:
Related Special Reports
...What at first seems accidental turns out to have been an assassination by a foreign power, using remote gene-editing technologies....
...I’d be happy to share our output if it would be helpful. WhatsApp to WesPete: Of course, we’d be thrilled to have you any time....
...John nods in agreement: “It’s in the Whitaker genes. Jack has inherited the determination to win,” he says....
...“We are poised to become a leader in immuno-dermatology, with a broad pipeline including 14 active R&D programmes.”...
...The fashion gene passed directly down then, I propose to Cristiana. Not fashion, she corrects me firmly. “Il bello.” Beauty. Coco nods. “She was passionate about all the small things....
...The group’s head of pharma, Stefan Oelrich, who moved to the job from rival Sanofi in 2018, axed 40 per cent of the old R&D programme, focusing on cell and gene therapy and spending billions of euros to...
...Biologists have been typing the names of genes, only to have Excel autocorrect those names into dates....
...Novo’s next generation drug CagriSema is biopharma’s most valuable R&D project, with a net present value of $30bn, according to Evaluate....
...At the start of this year, though, I felt a strong urge to embrace everything I’d normally reject. I have no idea why: perhaps it was the “serious person” gene finally kicking in. Whatever....
...You’d need 50, maybe 100, and you’d need a thousand square kilometres in which to put them.”...
...Development costs are estimated at $2.3bn per drug by Deloitte, leaving return on R&D investment at a pitiful 1.2 per cent. AI should improve matters by speeding up drug discovery....
...A few months before meeting Hooke’s team leader, Dr David Porter, I’d been told by an orthopaedic surgeon that I’d probably need a total knee replacement within four years....
...But lo, everyone from interior designer Nicky Haslam to rock-star offspring Gene Gallagher was in a tie. It was clearly a thing. And they’d done it in a louche, party-friendly way....
...“If Apple had the same number of weeks, they’d be up 7 per cent — the business is healthy,” he said....
...Join the dots: technologies like AI or gene editing cut across multiple different regulators (you need to consult 11 to put a satellite into space, for example) so in a modern economy regulators have to...
...“Compared to the billions spent annually on upstream R&D, the budget for downstream regulators to help get these innovations to market is minimal,” says Ringer at Form Ventures, who proposed eventually increasing...
...While genes may follow their own ageing path, we can still make changes to strengthen and renew the network — such as year-long sun protection and incorporating smart devices into a weekly skincare routine...
...expect, this scent evokes Ernst Lubitsch’s emotionally complex 1943 drama featuring the sublime Gene Tierney and Don Ameche....
...Timothy D Hunt Chief Executive, Alliance for Regenerative Medicine, Washington, DC, US...
...In our view, Note D(i) to heading 9503 of the EN to the HS (relied upon by both parties) supports that conclusion....
...There is now a risk that R&D switches focus from the drugs that are most needed, to those that avoid US price controls....
...They either rejoice or worry about AI refashioning our world, whether their lens is gene editing, geopolitics, climate — or any other facet of life....
...It’d be especially useful in situations where you will have multiple examples from the same person over time....
...Mene Pangalos, head of biopharmaceuticals R&D at AstraZeneca, said: “We are moving in a big way into cell therapies outside oncology, where they have been remarkably effective for treating some cancers.”...
...Letter in response to this article: Healthcare must embrace gene therapy to catch up with science / From Timothy D Hunt, Chief Executive, Alliance for Regenerative Medicine, Washington, DC, US...
International Edition